The Evergreen Forests of Insulin Patents

By: Connor Christensen

The prices of insulin have risen to unconscionable levels in just a little over two decades. What used to be a relatively minor expense for Americans with diabetes  has, for some, become an insurmountable obstacle to living a normal life, or, in some cases living at all. The purpose of this brief commentary is to address just one of the many issues attributed to the stark increase in insulin prices: patent evergreening.

People with Type I and Type II diabetes constantly depend on insulin injections to supplement their insufficient natural production of the blood-sugar regulating hormone in their pancreas.[1]  Without this hormone, a diabetic person’s life expectancy is short and riddled with many serious health complications.[2]  For many decades insulin was readily accessible and affordable for those who needed it.  Recently, however, things have changed.

Continue reading “The Evergreen Forests of Insulin Patents”